About Inhibikase Therapeutics

About company

Inhibikase Therapeutics has developed the first small molecule platform capable of treating both bacterial and viral infectious disease through a common mechanism of action in the host. The Company's host targeting strategy creates multi-pathogen anti-infectives without stimulating resistance.